(TPI)

Tianyin Pharmaceutical Co., Inc.

Close Price:
0.69

Change:
0.01 Stock Price Increase0.01

% Change:
0.0147058823529411764705882353 Stock Price Increase1.47 %

Date:
2/1/2012

52 Week:
0.56 - 2.79

Prev Close:
0.68

Open:
0.71

Volume:
92,420

90D Avg. Volume:
47,672

2/1/2012 Range:
0.69 - 0.73

Market Cap:
20,203,200

Trailing PE Ratio:
2.09

Shares Out:
29,280,000

EPS:
0.33

Yield:
0.00

Dividend:
0.00

Dividend Date:
3/9/2010

Quarter End:
3/31/2012

Tianyin Pharmaceutical Co., Inc.

Sector: Healthcare

Industry: Drug Manufacturers - Other

Website: www.tianyinpharma.com

Business Summary: Tianyin Pharmaceutical Co., Inc. engages in the development, manufacture, marketing, and sale of biopharmaceuticals, branded generics, modernized traditional Chinese medicines, and other pharmaceuticals in the People?s Republic of China. Its products are intended to address various medical needs in the therapeutic areas spanning internal medicines, gynecology, hepatology, otolaryngology, gastroenterology, neurology, orthopedics, and urology. The company manufactures and markets a portfolio of 58 products comprising biopharmaceuticals, branded generics, modernized traditional Chinese medicines, and other pharmaceuticals, as well as has a pipeline of 10 product candidates pending the approval by State Food and Drug Administration (SFDA) in China. It sells its products through regional distributors, as well as directly to the hospitals, clinics, and pharmacies. The company was founded in 1994 and is headquartered in Chengdu, the People?s Republic of China.


23rd Floor
UnionsunYangkuo PlazaNo 2
Chengdu, 610041 China ,
P: 86 28 8200 2232
F: 86 28 8551 6676

TPI Earnings Calendar

Q1:
Jul
1
 -
Sep
30
Q2:
Oct
1
 -
Dec
30
Q3:
Jan
1
 -
Mar
31
Q4:
Apr
1
 -
Jun
30
Period Ending
 
Assets
Current Assets
Cash & Cash Equivalents
Short Term Investments
Net Receivables
Inventory
Other Current Assets
Total Current Assets
Long Term Assets
Property Plant & Equipment
Goodwill
Intangible Assets
Accumulated Amortization
Other Assets
Deferred Long Asset Charges
Total Assets
Liabilities
Current Liabilities
Accounts Payable
Short/Current Long Term Debt
Other Current Liabilities
Total Current Liabilities
Long Term Debt
Other Liabilities
Deferred Long Term Liability Charges
Minority Interest
Negative Goodwill
Total Liabilities
Stockholders' Equity
Misc Stock Options Warrants
Redeemable Preferred Stock
Preferred Stock
Common Stock
Retained Earnings
Treasury Stock
Capital Surplus
Other Stockholder Equity
Total Stockholder Equity
Net Tangible Assets
6/30/2010
 
 
 
$27,009
$0
$8,480
$3,589
$0
$39,538
$0
$14,969
$0
$15,232
$0
$0
$0
$69,739
 
 
$5,558
$1,493
$429
$7,479
$0
$0
$0
$454
$0
$7,933
 
$0
$0
$1
$27
$0
($112)
$29,623
$6,578
$61,806
$46,574
  
 
 
 
  
  
  
  
  
  
  
  
  
  
  
  
  
  
 
 
  
  
  
  
  
  
  
  
  
  
 
  
  
  
  
  
  
  
  
  
  
YoY
 
 
 
118.7%
0.0%
50.9%
(5.8%)
0.0%
67.2%
0.0%
55.2%
0.0%
26.5%
0.0%
0.0%
0.0%
53.8%
 
 
108.3%
5.8%
39.3%
70.5%
0.0%
0.0%
0.0%
0.0%
0.0%
80.9%
 
0.0%
0.0%
(85.7%)
50.0%
0.0%
0.0%
50.4%
35.6%
50.9%
61.1%
  
 
 
 
  
  
  
  
  
  
  
  
  
  
  
  
  
  
 
 
  
  
  
  
  
  
  
  
  
  
 
  
  
  
  
  
  
  
  
  
  
6/30/2009
 
 
 
$12,352
$0
$5,621
$3,808
$0
$23,652
$0
$9,643
$0
$12,037
$0
$0
$0
$45,332
 
 
$2,668
$1,411
$308
$4,386
$0
$0
$0
$0
$0
$4,386
 
$0
$0
$7
$18
$0
($112)
$19,695
$4,851
$40,946
$28,908
  
 
 
 
  
  
  
  
  
  
  
  
  
  
  
  
  
  
 
 
  
  
  
  
  
  
  
  
  
  
 
  
  
  
  
  
  
  
  
  
  
YoY
 
 
 
2.4%
0.0%
16.3%
7.1%
0.0%
14.3%
0.0%
67.4%
0.0%
16.8%
0.0%
0.0%
0.0%
23.3%
 
 
12.4%
1.3%
115.4%
12.1%
0.0%
0.0%
0.0%
0.0%
0.0%
12.1%
 
0.0%
0.0%
(22.2%)
20.0%
0.0%
0.0%
9.4%
25.7%
24.7%
28.2%
  
 
 
 
  
  
  
  
  
  
  
  
  
  
  
  
  
  
 
 
  
  
  
  
  
  
  
  
  
  
 
  
  
  
  
  
  
  
  
  
  
Period Ending
 
Assets
Current Assets
Cash & Cash Equivalents
Short Term Investments
Net Receivables
Inventory
Other Current Assets
Total Current Assets
Long Term Assets
Property Plant & Equipment
Goodwill
Intangible Assets
Accumulated Amortization
Other Assets
Deferred Long Asset Charges
Total Assets
Liabilities
Current Liabilities
Accounts Payable
Short/Current Long Term Debt
Other Current Liabilities
Total Current Liabilities
Long Term Debt
Other Liabilities
Deferred Long Term Liability Charges
Minority Interest
Negative Goodwill
Total Liabilities
Stockholders' Equity
Misc Stock Options Warrants
Redeemable Preferred Stock
Preferred Stock
Common Stock
Retained Earnings
Treasury Stock
Capital Surplus
Other Stockholder Equity
Total Stockholder Equity
Net Tangible Assets
6/30/2010
 
 
 
$27,009
$0
$8,480
$3,589
$0
$39,538
$0
$14,969
$0
$15,232
$0
$0
$0
$69,739
 
 
$5,558
$1,493
$429
$7,479
$0
$0
$0
$454
$0
$7,933
 
$0
$0
$1
$27
$0
($112)
$29,623
$6,578
$61,806
$46,574
  
 
 
 
  
  
  
  
  
  
  
  
  
  
  
  
  
  
 
 
  
  
  
  
  
  
  
  
  
  
 
  
  
  
  
  
  
  
  
  
  
QoQ
 
 
 
118.7%
0.0%
36.3%
(5.8%)
0.0%
67.2%
0.0%
55.2%
0.0%
26.5%
0.0%
0.0%
0.0%
53.8%
 
 
107.5%
6.7%
39.3%
70.5%
0.0%
0.0%
0.0%
0.0%
0.0%
80.9%
 
0.0%
0.0%
(85.7%)
50.0%
0.0%
0.0%
50.4%
35.6%
50.9%
61.1%
  
 
 
 
  
  
  
  
  
  
  
  
  
  
  
  
  
  
 
 
  
  
  
  
  
  
  
  
  
  
 
  
  
  
  
  
  
  
  
  
  
3/31/2010
 
 
 
$23,259
$0
$8,551
$3,623
$0
$36,041
$0
$14,571
$0
$15,313
$0
$0
$0
$65,925
 
 
$6,036
$1,484
$504
$8,025
$0
$0
$0
$438
$0
$8,462
 
$0
$0
$2
$27
$0
($112)
$29,830
$4,898
$57,463
$42,150
  
 
 
 
  
  
  
  
  
  
  
  
  
  
  
  
  
  
 
 
  
  
  
  
  
  
  
  
  
  
 
  
  
  
  
  
  
  
  
  
  
QoQ
 
 
 
116.7%
0.0%
29.7%
(22.4%)
0.0%
63.9%
0.0%
75.7%
0.0%
21.1%
0.0%
0.0%
0.0%
53.5%
 
 
204.8%
6.1%
28.9%
112.8%
0.0%
0.0%
0.0%
0.0%
0.0%
124.4%
 
0.0%
0.0%
(77.8%)
68.8%
0.0%
(8.7%)
53.4%
1.9%
46.7%
59.0%
  
 
 
 
  
  
  
  
  
  
  
  
  
  
  
  
  
  
 
 
  
  
  
  
  
  
  
  
  
  
 
  
  
  
  
  
  
  
  
  
  
Period Ending
Net Income
Operating Activities
Depreciation
Adjustments To Net Income
Changes In Accounts Receivables
Changes In Liabilities
Changes In Inventories
Changes In Other Operating Activities
Total from Operating Activities
Investing Activities
Capital Expenditures
Investments
Other Investing Activities
Total from Investing Activities
Financing Activities
Dividends Paid
Sale Purchase of Stock
Net Borrowings
Other Financing Activites
Total from Financing Activities
Effect of Exchange Rate Changes
Change in Cash and Cash Equivalents
6/30/2010
$12,043
 
$954
$2,403
($2,770)
$752
$239
$607
$15,400
 
($5,809)
($293)
($503)
($8,845)
 
($1,409)
$440
$66
$8,895
$7,992
$110
$14,657
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
YoY
52.3%
 
40.9%
1,072.9%
(126.5%)
46.0%
200.4%
1,063.5%
84.7%
 
(37.1%)
0.0%
86.0%
(12.8%)
 
(1,804.1%)
492.9%
0.0%
0.0%
4,396.8%
946.2%
4,868.5%
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
6/30/2009
$7,908
 
$677
($247)
($1,223)
$515
($238)
($63)
$8,337
 
($4,238)
$0
($3,605)
($7,843)
 
($74)
($112)
$0
$0
($186)
($13)
$295
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
YoY
32.4%
 
81.5%
(305.8%)
(1.6%)
436.5%
83.0%
74.5%
124.8%
 
(337.8%)
0.0%
2.6%
(67.9%)
 
10.8%
(100.8%)
100.0%
0.0%
(101.5%)
(104.0%)
(97.4%)
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Period Ending
Net Income
Operating Activities
Depreciation
Adjustments To Net Income
Changes In Accounts Receivables
Changes In Liabilities
Changes In Inventories
Changes In Other Operating Activities
Total from Operating Activities
Investing Activities
Capital Expenditures
Investments
Other Investing Activities
Total from Investing Activities
Financing Activities
Dividends Paid
Sale Purchase of Stock
Net Borrowings
Other Financing Activites
Total from Financing Activities
Effect of Exchange Rate Changes
Change in Cash and Cash Equivalents
6/30/2010
$4,376
 
$275
$2,151
($45)
($169)
$48
$149
$6,802
 
($470)
$0
($648)
($3,358)
 
$168
$0
$0
$30
$198
$107
$3,750
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
QoQ
102.3%
 
(14.3%)
(12.5%)
95.3%
(158.3%)
(94.4%)
(70.4%)
72.9%
 
68.5%
0.0%
45.5%
(25.2%)
 
327.0%
100.0%
(100.0%)
0.0%
(54.0%)
272.6%
131.6%
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
3/31/2010
$2,909
 
$285
($841)
($113)
$304
($402)
$420
$3,718
 
($4,051)
$0
$2,887
($1,163)
 
($500)
$0
$66
$1,274
$840
($2)
$3,393
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
QoQ
53.4%
 
141.5%
0.0%
81.9%
25.6%
(1,927.3%)
136.0%
666.6%
 
(86.3%)
0.0%
2,303.8%
49.5%
 
0.0%
0.0%
164.1%
0.0%
915.5%
88.2%
274.9%
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Period Ending
Total Revenue
Cost of Revenue
Gross Profit
Operating Expenses
Research Development
Selling General & Administrative
Non Recurring
Others
Total Operating Expenses
Operating Income or Loss
Income from Continuing Operations
Total Other Income/Expenses Net
Earnings Before Interest And Taxes
Interest Expense
Income Before Tax
Income Tax Expense
Minority Interest
Net Income From Continuing Ops
 
Non-recurring Events
Discontinued Operations
Extraordinary Items
Effect Of Accounting Changes
Other Items
Net Income
Preferred Stock And Other Adjustments
Net Income Applicable To Common Shares
6/30/2010
$63,940
$30,595
$33,345
 
$853
$17,746
$0
$0
$0
$14,746
 
($40)
$14,681
$0
$14,681
$2,626
($12)
$12,043
 
 
$0
$0
$0
$0
$12,043
$0
$12,043
  
  
  
  
 
  
  
  
  
  
  
 
  
  
  
  
  
  
  
 
 
  
  
  
  
  
  
  
YoY
49.1%
42.2%
56.0%
 
148.0%
56.8%
(100.0%)
0.0%
0.0%
51.8%
 
(111.2%)
53.8%
(100.0%)
53.8%
60.2%
0.0%
52.3%
 
 
0.0%
0.0%
0.0%
0.0%
52.3%
0.0%
52.3%
  
  
  
  
 
  
  
  
  
  
  
 
  
  
  
  
  
  
  
 
 
  
  
  
  
  
  
  
6/30/2009
$42,894
$21,516
$21,378
 
$344
$11,318
$431
$0
$0
$9,717
 
$357
$9,547
$96
$9,547
$1,639
$0
$7,908
 
 
$0
$0
$0
$0
$7,908
$0
$7,908
  
  
  
  
 
  
  
  
  
  
  
 
  
  
  
  
  
  
  
 
 
  
  
  
  
  
  
  
YoY
28.2%
14.4%
45.9%
 
48.9%
65.0%
0.0%
0.0%
0.0%
28.4%
 
0.0%
26.1%
(73.9%)
32.6%
33.4%
0.0%
32.4%
 
 
0.0%
0.0%
0.0%
0.0%
32.4%
0.0%
32.4%
  
  
  
  
 
  
  
  
  
  
  
 
  
  
  
  
  
  
  
 
 
  
  
  
  
  
  
  
Period Ending
Total Revenue
Cost of Revenue
Gross Profit
Operating Expenses
Research Development
Selling General & Administrative
Non Recurring
Others
Total Operating Expenses
Operating Income or Loss
Income from Continuing Operations
Total Other Income/Expenses Net
Earnings Before Interest And Taxes
Interest Expense
Income Before Tax
Income Tax Expense
Minority Interest
Net Income From Continuing Ops
 
Non-recurring Events
Discontinued Operations
Extraordinary Items
Effect Of Accounting Changes
Other Items
Net Income
Preferred Stock And Other Adjustments
Net Income Applicable To Common Shares
12/31/2010
$25,334
$14,000
$11,334
 
$259
$5,747
$0
$0
$0
$5,328
 
$15
$5,334
$0
$5,334
$942
$9
$4,400
 
 
$0
$0
$0
$0
$4,400
$0
$4,400
  
  
  
  
 
  
  
  
  
  
  
 
  
  
  
  
  
  
  
 
 
  
  
  
  
  
  
  
QoQ
69.6%
95.0%
46.1%
 
31.5%
30.3%
0.0%
0.0%
0.0%
69.0%
 
0.0%
69.8%
100.0%
69.8%
64.7%
1,000.0%
71.3%
 
 
0.0%
0.0%
0.0%
0.0%
71.3%
0.0%
71.3%
  
  
  
  
 
  
  
  
  
  
  
 
  
  
  
  
  
  
  
 
 
  
  
  
  
  
  
  
9/30/2010
$21,951
$11,140
$10,811
 
$258
$5,987
$0
$0
$0
$4,566
 
$0
$4,575
$0
$4,575
$905
$8
$3,678
 
 
$0
$0
$0
$0
$3,678
$0
$3,678
  
  
  
  
 
  
  
  
  
  
  
 
  
  
  
  
  
  
  
 
 
  
  
  
  
  
  
  
QoQ
63.8%
75.5%
53.2%
 
34.4%
45.4%
0.0%
0.0%
0.0%
66.3%
 
100.0%
68.4%
(100.0%)
69.6%
77.5%
166.7%
68.0%
 
 
0.0%
0.0%
0.0%
0.0%
68.0%
0.0%
68.0%